NAAA
JAZZ icon

New Age Alpha Advisors’s Jazz Pharmaceuticals JAZZ Stock Holding History

New Age Alpha Advisors’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,482
Closed -$183K – 974
2024
Q4 		$183K Buy
+1,482
New +$175K 0.01% 671

Other funds holding JAZZ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

New Age Alpha Advisors's JAZZ Position: Q1 2025 in Review

New Age Alpha Advisors sold out of Jazz Pharmaceuticals (JAZZ) in Q1 2025, closing a stake of 1,482 shares — an estimated $183K sold.

New Age Alpha Advisors first reported a position in JAZZ in Q4 2024 and held it in 1 quarter. The position peaked at $183K in Q4 2024. 550 funds tracked by Wall St. Rank hold JAZZ as of Q1 2025.

  • New Age Alpha Advisors reported no remaining Jazz Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • New Age Alpha Advisors sold 1,482 Jazz Pharmaceuticals shares in Q1 2025, an estimated $183K.
  • New Age Alpha Advisors first reported a position in Jazz Pharmaceuticals in Q4 2024 and held it in 1 quarter.
  • New Age Alpha Advisors's Jazz Pharmaceuticals position peaked at $183K in Q4 2024.
  • 550 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2025.

Based on New Age Alpha Advisors's 13F filing for Q1 2025, filed 9 May 2025.